# Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency

Study · id `cardio:ct-nct02937454` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02937454](<https://clinicaltrials.gov/study/NCT02937454>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02937454

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1132 participants.

## Technical summary

Registry record NCT02937454. Randomized; triple masking; primary purpose treatment. Start 2017-04-03 (actual); primary completion 2020-07-21 (actual). Results posted on 2021-06-18.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1132 participants (enrolled count; ClinicalTrials.gov record NCT02937454, source copy `cardio:ctgov-nct02937454-2021-06-18`, retrieved 2026-10-26)
- Started: 2017-04-03 (actual) (ClinicalTrials.gov record NCT02937454, source copy `cardio:ctgov-nct02937454-2021-06-18`, retrieved 2026-10-26)
- Primary completion: 2020-07-21 (actual) (ClinicalTrials.gov record NCT02937454, source copy `cardio:ctgov-nct02937454-2021-06-18`, retrieved 2026-10-26)
- Completion: 2020-07-21 (actual) (ClinicalTrials.gov record NCT02937454, source copy `cardio:ctgov-nct02937454-2021-06-18`, retrieved 2026-10-26)
- Results first posted: 2021-06-18 (ClinicalTrials.gov record NCT02937454, source copy `cardio:ctgov-nct02937454-2021-06-18`, retrieved 2026-10-26)
- Countries: Argentina; Brazil; Croatia; Georgia; Israel; Italy; Lebanon; Netherlands; Poland; Romania; Singapore; Spain; Sweden; Ukraine; United Kingdom (ClinicalTrials.gov record NCT02937454, source copy `cardio:ctgov-nct02937454-2021-06-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02937454-2021-06-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
- Acronym: Affirm-AHF
- Condition: Iron Deficiency
- Condition: Heart Failure
- Intervention (Drug): ferric carboxymaltose
- Intervention (Other): Normal saline 0.9%
- Lead sponsor: Vifor (International) Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Worldwide Clinical Trials
- Collaborator class: OTHER
- Collaborator: Cytel Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record: Ferric carboxymaltose (`core:ferric-carboxymaltose`)
- Registry lists this organization as a collaborator: Worldwide Clinical Trials (`cardio:org-worldwide-clinical-trials`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (`cardio:pubmed-33197395`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis (`cardio:pubmed-37051919`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial (`cardio:pubmed-37592272`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function (`cardio:pubmed-37382961`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 1df1d171ce54d2a21ee499b4f2cc2779caf853400dffbcc7039ed263796ff3c9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
